Key financial trends that shape biotech business growth

Autor:	Alex K Pavlou, Mark J. Belsey
Rok vydání:	2005
Předmět:	Finance Net profit Economics and Econometrics business.industry Variable cost Biotechnology Investor relations Management of Technology and Innovation Market analysis Economics Revenue Strategic management Revenue growth business
Zdroj:	Journal of Commercial Biotechnology. 11:171-175
ISSN:	1478-565X 1462-8732
DOI:	10.1057/palgrave.jcb.3040114
Popis:	Datamonitor analysis has identified two key company categories currently shaping the biotech industry: the leading biotherapeutics players and the emerging biotherapeutics players. Analysis of financial trends of companies in these categories from 2001–2003 has revealed that, despite strong revenue growth recorded by the leading biotherapeutics players, highly variable cost bases strongly affected net profits. Conversely, the emerging biotherapeutics players saw a decline in revenue growth, due to a reduction in collaboration or licensing revenue. Both leading and emerging biotherapeutics players strongly increased R&D spend over this period. Future growth of the leading and emerging biotherapeutics sectors will be driven primarily by M&A/licensing agreements, and in-house pipeline development driven by continued strong R&D spend.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::09f903f753bb79b307654dbff8f0c895 https://doi.org/10.1057/palgrave.jcb.3040114 Zobrazit plný text záznamu Plný text ve formátu PDF